Filter by: patients
What is Talampanel?

A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS) Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
ALS (Amyotrophic Lateral Sclerosis) 16 10 Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 5 1 Efficacy_cant_tell
Participate in clinical trial 2 2 Efficacy_none
drug trail 2 1 Efficacy_none

See all 9 patients currently taking Talampanel

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
2
Moderate
2
Mild
2
None
6

Reported Stop Reasons

Why Patients Stopped Taking Talampanel (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 7   Did not seem to work: 58%
Course of treatment ended 4   Course of treatment ended: 33%
Doctor's advice 2   Doctor's advice: 17%
Side effects too severe 2   Side effects too severe: 17%
Other 2   Other: 17%

See all 12 patients who’ve stopped taking Talampanel

Currently Taking Talampanel

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Talampanel

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Talampanel

Always
9 75%
Usually
1 8%
Sometimes
1 8%
Never
1 8%

Burden

Difficulty being on treatment

Burden of Talampanel

Very
1 8%
Somewhat
1 8%
A little
3 25%
Not at all
7 58%

Cost

Paid out of pocket

Cost of Talampanel

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
7 100%

Report created on February 11, 2012.